Abstract
OBJECTIVES
This study aims to assess the effect of vocal fold injection augmentation (IA) on subsequent medialization laryngoplasty (ML).
STUDY DESIGN
A retrospective cohort study with follow-up telephone survey was carried out.
METHODS
Clinical records of patients with unilateral vocal fold paralysis or paresis (VFP) who underwent ML between April 2006 and March 2015 were reviewed. Patients who underwent IA before ML were compared with patients who did not, with respect to demographic information, symptoms, Voice Handicap Index-10 (VHI-10), etiology of VFP, and revision rate. Among patients undergoing IA, the effects of injection material and of interval from IA to ML on revision rate were assessed. Follow-up telephone surveys were conducted to evaluate long-term outcomes using VHI-10 and a condition-specific questionnaire.
RESULTS
One hundred thirty-five patients (70 male:65 female) with vocal fold paralysis (125) or paresis (10) underwent ML (96 left:39 right). Sixty-six (48.9%) patients underwent concurrent arytenoid adduction. Fourteen (10.4%) patients required revision. Fifty-six (41.5%) patients had prior IA; five (8.9%) patients underwent revision. Seventy-nine (58.5%) patients did not have IA; nine (11.4%) patients required revision (P = 0.78). Neither augmentation material nor length of interval between last IA and ML affected the revision rate (P = 1.00; P ≥ 0.11 for all tested intervals, respectively). No difference in follow-up VHI-10 score was found between patients who had IA before ML and patients who had not (P = 0.73).
CONCLUSIONS
IA does not appear to affect the revision rate or long-term outcome of subsequent ML.
TY - JOUR
T1 - Medialization Laryngoplasty After Injection Augmentation.
AU - Silva Merea,Valeria,
AU - Husain,Solomon,
AU - Sulica,Lucian,
Y1 - 2017/07/03/
PY - 2017/02/21/received
PY - 2017/05/05/revised
PY - 2017/05/10/accepted
PY - 2017/7/8/pubmed
PY - 2018/9/5/medline
PY - 2017/7/8/entrez
KW - Injection augmentation
KW - Medialization laryngoplasty
KW - Outcome
KW - Vocal fold paralysis
KW - Vocal fold paresis
SP - 249
EP - 255
JF - Journal of voice : official journal of the Voice Foundation
JO - J Voice
VL - 32
IS - 2
N2 - OBJECTIVES: This study aims to assess the effect of vocal fold injection augmentation (IA) on subsequent medialization laryngoplasty (ML). STUDY DESIGN: A retrospective cohort study with follow-up telephone survey was carried out. METHODS: Clinical records of patients with unilateral vocal fold paralysis or paresis (VFP) who underwent ML between April 2006 and March 2015 were reviewed. Patients who underwent IA before ML were compared with patients who did not, with respect to demographic information, symptoms, Voice Handicap Index-10 (VHI-10), etiology of VFP, and revision rate. Among patients undergoing IA, the effects of injection material and of interval from IA to ML on revision rate were assessed. Follow-up telephone surveys were conducted to evaluate long-term outcomes using VHI-10 and a condition-specific questionnaire. RESULTS: One hundred thirty-five patients (70 male:65 female) with vocal fold paralysis (125) or paresis (10) underwent ML (96 left:39 right). Sixty-six (48.9%) patients underwent concurrent arytenoid adduction. Fourteen (10.4%) patients required revision. Fifty-six (41.5%) patients had prior IA; five (8.9%) patients underwent revision. Seventy-nine (58.5%) patients did not have IA; nine (11.4%) patients required revision (P = 0.78). Neither augmentation material nor length of interval between last IA and ML affected the revision rate (P = 1.00; P ≥ 0.11 for all tested intervals, respectively). No difference in follow-up VHI-10 score was found between patients who had IA before ML and patients who had not (P = 0.73). CONCLUSIONS: IA does not appear to affect the revision rate or long-term outcome of subsequent ML.
SN - 1873-4588
UR - https://www.unboundmedicine.com/medline/citation/28684252/Medialization_Laryngoplasty_After_Injection_Augmentation_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0892-1997(17)30088-7
DB - PRIME
DP - Unbound Medicine
ER -